123 related articles for article (PubMed ID: 668151)
1. The turnover time of calcium in the exchangeable pools of bone in man and the long-term effect of a parathyroid hormone fragment.
Reeve J
Clin Endocrinol (Oxf); 1978 Jun; 8(6):445-55. PubMed ID: 668151
[TBL] [Abstract][Full Text] [Related]
2. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
Reeve J; Arlot M; Bernat M; Charhon S; Edouard C; Slovik D; Vismans FJ; Meunier PJ
Metab Bone Dis Relat Res; 1981; 3(1):23-30. PubMed ID: 7266363
[No Abstract] [Full Text] [Related]
3. Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.
Slovik DM; Neer RM; Potts JT
J Clin Invest; 1981 Nov; 68(5):1261-71. PubMed ID: 7298851
[TBL] [Abstract][Full Text] [Related]
4. Intestinal absorption of calcium in greyhounds: the response to intermittent and continuous administration of human synthetic parathyroid hormone fragment 1-34 (hPTH 1-34).
Podbesek RD; Mawer EB; Zanelli GD; Parsons JA; Reeve J
Clin Sci (Lond); 1984 Dec; 67(6):591-9. PubMed ID: 6548427
[TBL] [Abstract][Full Text] [Related]
5. Bone calcium exchange in primary hyperparathyroidism as measured by 47calcium kinetics.
Knop J; Montz R; Schneider C; Stritzke P; Dorn-Quint G; Nordmeyer JP; Kruse HP; Kuhlencordt F
Metabolism; 1980 Sep; 29(9):819-25. PubMed ID: 7412556
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
Kurland ES; Cosman F; McMahon DJ; Rosen CJ; Lindsay R; Bilezikian JP
J Clin Endocrinol Metab; 2000 Sep; 85(9):3069-76. PubMed ID: 10999788
[TBL] [Abstract][Full Text] [Related]
8. Response of the parathyroid gland to infusion of human parathyroid hormone-(1-34) [PTH-(1-34)]: demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1-84) assay.
Cosman F; Shen V; Herrington B; Lindsay R
J Clin Endocrinol Metab; 1991 Dec; 73(6):1345-51. PubMed ID: 1955517
[TBL] [Abstract][Full Text] [Related]
9. Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone.
Hefti E; Trechsel U; Bonjour JP; Fleisch H; Schenk R
Clin Sci (Lond); 1982 Apr; 62(4):389-96. PubMed ID: 6461466
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone: a double-edged sword for bone metabolism.
Qin L; Raggatt LJ; Partridge NC
Trends Endocrinol Metab; 2004 Mar; 15(2):60-5. PubMed ID: 15036251
[TBL] [Abstract][Full Text] [Related]
11. Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.
Hesch RD; Heck J; Delling G; Keck E; Reeve J; Canzler H; Schober O; Harms H; Rittinghaus EF
Klin Wochenschr; 1988 Oct; 66(19):976-84. PubMed ID: 3141672
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
Plotkin H; Gundberg C; Mitnick M; Stewart AF
J Clin Endocrinol Metab; 1998 Aug; 83(8):2786-91. PubMed ID: 9709948
[TBL] [Abstract][Full Text] [Related]
14. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis.
Reeve J; Hesp R; Williams D; Hulme P; Klenerman L; Zanelli JM; Darby AJ; Tregear GW; Parsons JA
Lancet; 1976 May; 1(7968):1035-8. PubMed ID: 57447
[TBL] [Abstract][Full Text] [Related]
15. Serum calcium and bone: effect of PTH, phosphate, vitamin D and uremia.
Levine BS; Rodríguez M; Felsenfeld AJ
Nefrologia; 2014; 34(5):658-69. PubMed ID: 25259820
[TBL] [Abstract][Full Text] [Related]
16. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.
Slovik DM; Rosenthal DI; Doppelt SH; Potts JT; Daly MA; Campbell JA; Neer RM
J Bone Miner Res; 1986 Aug; 1(4):377-81. PubMed ID: 3503551
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone effects on skeletal exchangeable calcium and bone blood flow.
Brindley GW; Williams EA; Bronk JT; Meadows TH; Montgomery RJ; Smith SR; Kelly PJ
Am J Physiol; 1988 Jul; 255(1 Pt 2):H94-100. PubMed ID: 3394830
[TBL] [Abstract][Full Text] [Related]
18. Pathological and therapeutic implications of the cellular and humoral responses to parathyrin.
Parsons JA; Meunier P; Podbesek R; Reeve J; Stevenson RW
Biochem Soc Trans; 1981 Oct; 9(5):383-6. PubMed ID: 7026314
[No Abstract] [Full Text] [Related]
19. Priliminary trial of low doses of human parathyroid hormone 1-34 peptide in treatment of osteoporosis.
Reeve J; Tregear GW; Parsons JA
Calcif Tissue Res; 1976 Aug; 21 Suppl():469-77. PubMed ID: 782668
[No Abstract] [Full Text] [Related]
20. Effect of bicarbonate feeding on immobilization osteoporosis in the rat.
Orsatti MB; Fucci LL; Valenti JL; Puche RC
Calcif Tissue Res; 1976 Dec; 21(3):195-205. PubMed ID: 1000336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
